Abstract
Breast cancer is the leading cause of cancer mortality among women and these patients are under the risk of developing metastases. The heterogeneous nature of these metastases makes it difficult not only the definition of healing, as well as the risk factors for its development. Currently, some prognostic markers already assist clinical practice, and the most used are hormone receptors (E…